Support Of Pincer Nail Correction — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for support of pincer nail correction. 8 active patents protecting 1 drugs from 1+ originators. First major cliff: 2031. Daily refresh.

1
Approved drugs
8
Active US patents
64/100
Avg vulnerability
—
Annual revenue covered

Originators in Support Of Pincer Nail Correction

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Bristol-Myers Squibb 8 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating support of pincer nail correction. Each bar = one year. Y-axis scaled to peak year (7 patents).

1
31
7
32

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Acetadote
Acetylcysteine
 Bristol-Myers Squibb 8 64 — 2031-07-21

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8722738 Acetadote method of use 73 2032-04-06
9327028 Acetadote method of use 68 2031-07-21
8747894 Acetadote method of use 68 2032-05-08
9561204 Acetadote method of use 68 2032-05-08
8747894 Acetadote method of use 68 2032-05-08
9561204 Acetadote method of use 68 2032-05-08
9427421 Acetadote formulation 48 2032-05-08
9427421 Acetadote formulation 48 2032-05-08

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9427421 Acetadote formulation 48 2032-05-08
9427421 Acetadote formulation 48 2032-05-08
8747894 Acetadote method of use 68 2032-05-08
9561204 Acetadote method of use 68 2032-05-08
8747894 Acetadote method of use 68 2032-05-08
9561204 Acetadote method of use 68 2032-05-08
9327028 Acetadote method of use 68 2031-07-21
8722738 Acetadote method of use 73 2032-04-06

Related